8LIU J, SUKHOVA G K, YANG J T, et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells [J]. Atherosclerosis, 2006,184 : 302 - 311.
9SOFIA J, DIRK M W, ALLAN S, et al. Differential expression of cysteine and aspartie proteases during progression of atherosclerosis in apolipoprotein E-deficient mice[J]. Am J Pathol,2002,161:939-945.
10LI W, YUAN X M. Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis[J]. Ann N Y Acad Sci, 2004,1030:427-433.
5Van Gelder IC,Crijns HJ,Tieleman RG,et al.Chronic atrial fibrilla-tion.Success of serial cardioversion therapy and safety of oral anticoag-ulation[J].Arch Intern Med,2006,156(22):2585-2592.
6Ridker PM.High-sensitivity C-reactive protein:potential adjunct forglobal risk assessment in the primary prevention of cardiovascular dis-ease[J].Circulation,2007,103(13):1813-1818.
7Ewy GA,Ulfers L,Hager WD,et al.Response of atrial fibrillation totherapy:role of etiology and left atrial diameter[J].J Electrocardiol,2008,13(4):119-123.
8Chung MK,Martin DO,Sprecher D,et al.C-reactive protein elevationin patients with atrial arrhythmias:inflammatory mechanisms and per-sistence of atrial fibrillation[J].Circulation,2001,104(24):2886-2891.
9Benjamin EJ,Wolf PA,D’Agostino RB,et al.Impact of atrial fibrilla-tion on the risk of death:the Framingham Heart Study[J].Circula-tion,1998,98(10):946-952.
10SCHINDHELM R K, DEKKER J M, NIJPELS G, et al Alanini aminotransferase predicts coronary heart disease events a 10-year-follow-up of the Hoom Study [J ]. Atheroslerosis, 2007 191(2) : 391-396.
